Medico Remedies Limited (BOM:540937)
43.68
-1.33 (-2.95%)
At close: Aug 17, 2026
Medico Remedies Revenue
Medico Remedies had revenue of 705.69M INR in the quarter ending June 30, 2026, with 84.49% growth. This brings the company's revenue in the last twelve months to 2.38B, up 50.28% year-over-year. In the fiscal year ending March 31, 2026, Medico Remedies had annual revenue of 2.06B with 36.73% growth.
Revenue (ttm)
2.38B
Revenue Growth
+50.28%
P/S Ratio
1.52
Revenue / Employee
11.18M
Employees
213
Market Cap
3.62B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.06B | 554.37M | 36.73% |
| Mar 31, 2025 | 1.51B | 60.20M | 4.15% |
| Mar 31, 2024 | 1.45B | 44.83M | 3.19% |
| Mar 31, 2023 | 1.40B | 194.16M | 16.04% |
| Mar 31, 2022 | 1.21B | -13.69M | -1.12% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Albert David | 3.64B |
| Medicamen Biotech | 2.06B |
| Ambalal Sarabhai Enterprises | 1.99B |
| Everest Organics | 1.92B |
| Gennex Laboratories | 1.78B |
| Jenburkt Pharmaceuticals | 1.69B |
| Astonea Labs | 1.48B |
| Trident Lifeline | 1.39B |
Medico Remedies News
- 11 months ago - Medico Remedies shares surge nearly 5% after winning $1.78 million order from Turkmenistan government - Business Upturn